NNSCF yields 1.28% · MRK yields 2.76%● Live data
📍 NNSCF pulled ahead of the other in Year 4
Combined, NNSCF + MRK cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of NNSCF + MRK for your $10,000?
NEC Networks & System Integration Corporation operates as a telecommunications infrastructure construction company in Japan and internationally. It operates through Digital Solutions Business, Network Infrastructures Business, and Engineering & Support Services Business segments. The Digital Solutions Business segment offers system integration services related to ICT platform and outsourcing/cloud services for business of enterprises and other customers, as well as solutions/services for customers' business transformation by using cutting-edge/digital technologies and contact center services. The Network Infrastructures Business segment provides system integration/services related to network infrastructures to telecom carriers, central and local governments, and social infrastructures service providers; and develops, manufactures, and sells network equipment. The Engineering & Support Services Business segment offers support services, such as maintenance and operations/monitoring related to ICT systems/services; and operations of company-wide service infrastructures. Its products include telephony servers, video conferencing systems, routers, switches, network testers, interface converters, load balancers, accelerators, Internet traffic, SSL-VPN access, firewalls, unauthorized access detection, authentication systems, operation and maintenance, spam blocking, physical security, log management, industry and task-specific applications, and software. NEC Networks & System Integration Corporation was incorporated in 1953 and is headquartered in Tokyo, Japan.
Full NNSCF Calculator →Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.
Full MRK Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.